NYSEARCA:SYNB Putnam BioRevolution ETF (SYNB) Price, Holdings, & News → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free SYNB Stock Alerts $29.67 +0.66 (+2.28%) (As of 10:48 AM ET) Add Compare Share Share Today's Range$29.67▼$29.6750-Day Range$28.68▼$31.0652-Week Range$24.47▼$31.10Volume112 shsAverage Volume1,172 shsMarket Capitalization$5.19 millionAssets Under Management$5.07 millionDividend Yield0.00%Net Expense Ratio0.70% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Putnam BioRevolution ETF alerts: Email Address About Putnam BioRevolution ETFThe Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is managed by Putnam.Read More SYNB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SYNB ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive SYNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerPutnam Investments Fund NamePutnam BioRevolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SYNB Inception Date9/29/2022 Fund ManagerWilliam Rives WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings39 Fund Statistics Assets Under Management$5.02 million Average Daily Volume$0.00 Discount/Premium0.01% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorPutnam Investment Management, LLC CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerRBC Capital Markets Miscellaneous Outstanding Shares175,000Beta0.95 Creation Fee$250.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad DTIHere’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.Weekend after weekend! Putnam BioRevolution ETF ExpensesTypeSYNBTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.70%0.57%0.54%0.50%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.70%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%Net Expense0.70%0.59%0.60%0.57%0.58% Putnam BioRevolution ETF (SYNB) HoldingsTop 10 SYNB HoldingsThermo Fisher Scientific(NYSE:TMO)Holding Weight: 7.33%Danaher(NYSE:DHR)Holding Weight: 6.95%NVIDIA(NASDAQ:NVDA)Holding Weight: 6.87%Bio-Rad Laboratories(NYSE:BIO)Holding Weight: 5.37%Alphabet(NASDAQ:GOOGL)Holding Weight: 5.14%Novozymes A/S(OTCMKTS:NVZMY)Holding Weight: 4.41%Corteva(NYSE:CTVA)Holding Weight: 4.38%AbbVie(NYSE:ABBV)Holding Weight: 4.20%Ascendis Pharma A/S(NASDAQ:ASND)Holding Weight: 3.94%Net CashHolding Weight: 3.59%Full Holdings Details Similar ETFsJPM Carbon Transition US Equity ETFNYSEARCA:JCTRProShares Big Data Refiners ETFNYSEARCA:DATProShares Metaverse ETFNYSEARCA:VERSVirtus Duff & Phelps Clean Energy ETFNYSEARCA:VCLNDefiance Next Gen Altered Experience ETFNYSEARCA:PSY SYNB ETF - Frequently Asked Questions How have SYNB shares performed in 2024? Putnam BioRevolution ETF's stock was trading at $29.10 on January 1st, 2024. Since then, SYNB shares have increased by 2.0% and is now trading at $29.67. View the best growth stocks for 2024 here. What does SYNB invest in? Putnam BioRevolution ETF is a equity fund issued by Putnam Investments. SYNB focuses on theme investments. The fund's investments total to approximately $5.07 million assets under management. What stocks does Putnam BioRevolution ETF hold? SYNB invests in 39 holdings. Some of the stocks in their portfolio include Thermo Fisher Scientific (TMO), Danaher (DHR), NVIDIA (NVDA), Bio-Rad Laboratories (BIO), Alphabet (GOOGL), Novozymes A/S (NVZMY), Corteva (CTVA), AbbVie (ABBV), Ascendis Pharma A/S (ASND) and Eli Lilly and Company (LLY). What is the management fee for Putnam BioRevolution ETF? Putnam BioRevolution ETF's management fee is 0.70% and has no other recorded expenses or fee waivers. The net expense ratio for SYNB is 0.70%. How do I buy shares of Putnam BioRevolution ETF? Shares of SYNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:SYNB) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
